StockData

Jaguar Health vs Sunshine Biopharma

JAGX and SBFM side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How JAGX and SBFM compare

Sunshine Biopharma is the larger company, worth 4.6 times as much as Jaguar Health ($10.1M against $2.2M).

Jaguar Health grew revenue faster over the last twelve months (136% versus −2.7% for Sunshine Biopharma).

Sunshine Biopharma scores higher on the StockData Score (10 against 3 for Jaguar Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricJAGXSBFM
Size and price
Market cap$2.2M$10.1M
Share price$0.420$2.60
Change, 1 year−100.0%−99.2%
Change, 5 years−100%−78.3%
Employees4750
StockData Score
Total score310 (better)
Valuation score11
Growth score2 (better)1
Performance score03 (better)
Health score05 (better)
Dividend score00
Valuation
P/S0.1× (better)0.3×
P/B–0.4×
FCF yield–−53.3%
Growth
Revenue growth (TTM)136% (better)−2.7%
Revenue growth, 5Y average4.2%248% (better)
Profitability
Gross margin82.3% (better)30.3%
Operating margin−93.1%−16.6% (better)
Net margin–−16.5%
FCF margin–−15.2%
Return on equity–−21.9%
Return on invested capital–−31.9%
Financial health
Debt / equity–0.00
Interest coverage−25.9×–
Current ratio0.695.46 (better)
Altman Z-score−18.45−0.88 (better)
Piotroski F-score24 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions–2.1%
Held by insiders17.1%1.8%
Short interest, % of float4.7%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.